Patrick Dougherty

Company: Entrada Therapeutics Inc.

Job title: Scientist

Seminars:

Development of Endosomal Escape Vehicles (EEV) to Enhance the Functional Delivery of Oligonucleotides 3:00 pm

The EEV platform consists of a library of proprietary cyclic peptides with unique chemistry that enable improved uptake and endosomal escape EEV-therapeutics can be designed to enhance functional delivery to target tissues EEV-oligonucleotide corrected splicing deficits in preclinical models of neuromuscular diseasesRead more

day: Day One

Roundtable Discussion: What’s Next on the Horizon? Disease Model Indicators for a Targeted Intracellular Delivery Approach 12:00 pm

What disease indications could most benefit from intracellular drug delivery investment? Will specific payloads / technologies witness accelerated progress over the next 12 months? Utilize this unique industry touchpoint to discuss and gain and understanding of where intracellular targeted delivery platform efforts should be diverted to support novel pipeline progression and research collaborationsRead more

day: Day Two